Pharmaceuticals, Inc., a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia, today announced that eight abstracts on ferumoxtytol, its lead product candidate, have been accepted for presentation at the American Society of Nephrology meeting.
Genetic Immunity LLC, a clinical stage biopharmaceutical company and a leader in the development of DNA based nanoparticle immunotherapies, announced today the completion of a $2 million dollar bridge financing.
JPK Instruments, the market leader in BioSPM, has further expanded the premises of its Berlin headquarters to take account of the continuing growth in personnel and the increasing demand for JPK products.
NaturalNano, Inc., a developer of advanced nanomaterials and additive technologies, announced it has signed an exclusive licensing agreement with the U.S. Naval Research Laboratory spanning multiple industries and broad patents in controlled-release nanomaterials.
Insert Therapeutics, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today that its lead anti-cancer compound, IT-101, will be featured in a public television documentary series produced by Thirteen/WNET New York and the California Institute of Technology (Caltech).
Veeco Instruments Inc. today announced that it has introduced its new TurboDisc E475 As/P Metal Organic Chemical Vapor Deposition (MOCVD) system to be used in the production of red, orange, yellow (R/O/Y) high-brightness light emitting diodes (HB-LEDs) and multi-junction III-V concentrator solar cells, primarily for space applications.
Pure H2O, Inc., a provider of novel water and wastewater treatment systems, is pleased to announce that it has been approached by several interested parties with regards to Canadian distribution of its soon to be commercialized under sink unit.
In response to recent technological breakthroughs and a doubling of research and development funding by Octillion Corp, the Company is pleased to announce that, in addition to recently added managerial and support staff, it has increased its research staff to four, with plans to further boost research personnel, contingent upon ongoing results from the development of the Company's first-of-its-kind transparent glass window capable of generating electricity.